跳转至内容
Merck
CN
  • Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery.

Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery.

Journal of investigative surgery : the official journal of the Academy of Surgical Research (2014-09-03)
Andreas Alexandrou, Eleni Armeni, George Kaparos, Demetrios Rizos, Evangelia Tsoka, Efthymios Deligeoroglou, Maria Creatsa, Areti Augoulea, Theodoros Diamantis, Irene Lambrinoudaki
摘要

To evaluate the association between the Bsm1 vitamin D receptor polymorphism and the calcium-vitamin D-parathormone axis following bariatric surgery. This cross-sectional study included 86 morbidly obese patients, who underwent either gastric bypass or sleeve gastrectomy, with a mean follow-up of four years. Calcium metabolism indices and bone turnover markers were assessed according to the presence of secondary hyperparathyroidism and the Bsm1 vitamin D receptor genotypes. Secondary hyperparathyroidism (42.2% of sample) was associated with lower levels of 25hydroxyvitamin D and elevated markers of bone turnover. In subjects without secondary hyperparathyroidism, presence of the unfavorable B allele resulted in higher levels of parathormone (Bb and BB vs. bb genotype: 50.3 ± 8.2 pg/dl vs. 44.4 ± 10.7 pg/dl, p = .011, adjusted for weight loss, baseline body mass index, 25hydroxyvitamin D, surgical procedure, and duration after surgery). In the whole sample, patients bearing the unfavorable B allele exhibited lower weight loss, a parameter that was negatively associated with markers of bone resorption. Secondary hyperparathyroidism is highly prevalent after bariatric surgery. Bsm1 vitamin D receptor polymorphism may have an effect in early stages of calcium metabolism imbalance, while no association is detected in patients who have already developed secondary hyperparathyroidism. Moreover, vitamin D receptor polymorphism is associated with post-surgery weight loss, a process related to bone turnover.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
胆固醇, Sigma Grade, ≥99%
Sigma-Aldrich
对乙酰氨基苯酚, 98%
Sigma-Aldrich
盐酸 溶液, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
盐酸, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
盐酸, 37 wt. % in H2O, 99.999% trace metals basis
Supelco
对乙酰氨基酚, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
盐酸, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., fuming, ≥37%, APHA: ≤10
Sigma-Aldrich
盐酸, 36.5-38.0%, BioReagent, Molecular Biology
Sigma-Aldrich
胆固醇, powder, BioReagent, suitable for cell culture, ≥99%
Supelco
盐酸 溶液, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
荧光素, suitable for fluorescence, free acid
USP
对乙酰氨基酚, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
SyntheChol ® NS0 补充, 500 ×, synthetic cholesterol, animal component-free, aqueous solution, sterile-filtered, suitable for cell culture
Sigma-Aldrich
氯化氢 溶液, 1.0 M in diethyl ether
Sigma-Aldrich
对乙酰氨基酚, BioXtra, ≥99.0%
Supelco
利多卡因, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
盐酸 溶液, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
胆固醇, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
对乙酰氨基酚, meets USP testing specifications, 98.0-102.0%, powder
Supelco
奥美拉唑, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
胆固醇, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
氯化氢 – 甲醇 溶液, ~1.25 m HCl (T), derivatization grade (GC derivatization), LiChropur
Sigma-Aldrich
对乙酰氨基酚, analytical standard
Sigma-Aldrich
盐酸 溶液, 32 wt. % in H2O, FCC
Supelco
胆固醇 溶液, certified reference material, 10 mg/mL in chloroform
扑热息痛, European Pharmacopoeia (EP) Reference Standard
USP
利多卡因, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
奥美拉唑, solid